Abstract
Among mediastinal masses, about half are primary tumors in the anterior mediastinum, both benign and malignant. A variety of nonneoplastic lesions (developmental, inflammatory, reactive) can present as a localized mass in this compartment involving the thymus. Ectopic/embryonic remnants also occur in the prevascular compartment of the mediastinum. Rare tumors may develop from each of the multiple tissue types located in this vital area. The purpose of this chapter is to provide a short morphologic/photographic overview of lymphomas and of other rare tumors of mesenchymal type and of germ cell tumors occurring in the thymus or in the anterior mediastinum area. Selected examples of pseudotumors will also be shown. Specific differential diagnostic points are provided, both for “solid” tumors and for hematological malignancies. The main immunohistochemical characteristics of neoplastic/nonneoplastic pathology and updated specific references are discussed.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Mediastinum
- Mediastinal tumors
- Thymus
- Pathology
- Rare tumors
- Pseudotumors
- Differential diagnosis
- Immunohistochemistry
- Lymphoma
- Castleman disease
- Accessory cell sarcoma
- Mesenchymal tumors
- Sarcomas
- Ewing sarcoma
- Germ cell tumors
13.1 Introduction
The incidence of mediastinal masses in the general population is estimated to be one case per 100,000 persons per year, malignancy being more frequent in anterior mediastinal masses [1,2,3]. The distribution of the wide variety of tumors and of nonneoplastic lesions varies according to age and gender [4]. Moreover the anterior mediastinum (also named prevascular compartment) is the most common location of neoplasia (68%) in adults, whereas the posterior mediastinum is more frequently affected in children (52%) [5]. The most common abnormalities encountered in the prevascular compartment include benign thymic lesions (cysts, hyperplasia) and intrathoracic goiter. Malignancies include thymoma, thymic carcinoma, neuroendocrine thymic tumors (all together collectively indicated also as thymic epithelial tumors, TET), lymphoma, mesenchymal tumors and germ cell tumors (GCT), and metastatic tumors [6]. Frequencies are provided for the main entities among anterior mediastinal masses: thymic malignancy occurs in approximately 35%, lymphoma in approximately 25% , thyroid and other endocrine tumors in approximately 15%, benign teratoma in approximately 10%, malignant GCT in approximately 10% (seminoma, 4%, and non-seminomatous germ cell tumors (NSGCT), 7%), and benign thymic lesions in approximately 5% [7]. However, several other cell types and ectopic tissues in the mediastinum may give rise to a variety of other tumors rarer than TET.
Most of the tumors in the anterior mediastinum arise in the thymus. It may be very difficult to distinguish if an anterior mediastinal tumor has an extrathymic or intrathymic origin, particularly for large masses. Most of the thymic tumors arise from its main cellular components, epithelial and lymphoid.
Ectopic thymic tissue may be found along the embryonal route of descent as well as in different areas of the mediastinum/thoracic cavity which give rise to related tumors at these sites [8, 9]. Metastasis occurs in the thymus, although specific localization into thymus or anterior/middle mediastinal lymph nodes is difficult to demonstrate [10]. The metastases constitute the prevailing neoplastic pathology in the mediastinum [11].
13.2 Lymphoma of the Thymus/Anterior Mediastinum
Lymphomas occurring in the thymus belong both to T and B cell lineage or are Hodgkin lymphomas. They account for approximately 25% (13% of cases are Hodgkin lymphomas (HL) and 12% are non-Hodgkin lymphomas (NHL) of mediastinal tumors. However, only approximately 3% of HL and 6% of NHL arise as primary mediastinal malignancies. In fact, about 50% of HL and 20% of NHL involve the mediastinum in the framework of a systemic involvement [7]. In patients with a mediastinal component of generalized NHL, the involvement is mostly seen in mediastinal and hilar lymph nodes [12].
The two most common histologic subtypes that present with localized mediastinal involvement, primary mediastinal B lymphoma (PMBL) and T-lymphoblastic lymphoma (T-Lb), appear to arise from thymic tissue [13, 14]. The age-related specific subtype incidence is discussed in several papers [2, 15, 16].
A detailed classification and morphological/clinical overview of the different lymphoma types and their diagnosis can be accessed from various references [17,18,19,20,21,22,23].
In the subsequent section, examples of the most common mediastinal/primary thymic lymphoma, their main immunohistochemical markers, and morphological peculiarity/diagnostic pitfalls will be discussed. In addition, rare tumorlike lesions of relevant interest for their complex pathogenesis, heterogeneity of clinical features, constituting specific and rare biological entities such as Castleman disease occurring in the mediastinum [24,25,26,27] and in the thymus [28], and IgG4-related disease [29, 30] will be described.
13.3 Primary Lymphoma in the Anterior Superior Mediastinum
Lymphomas of immature precursor cells (T and B) and of peripheral T and B cells occur in the thymus. However, Hodgkin lymphoma of classic type (cHL), particularly the nodular sclerosis (NS) subtype, represents the most frequent mediastinal lymphoma. Among the lymphomas occurring in the mediastinum, T-cell lymphomas of precursor type predominate in pediatric age, whereas, in the adults, the most frequent lymphomas are of B cell origin, primary cHL of the thymus being rarely observed [15, 16, 31]. Table 13.1 lists the main immunophenotypical markers to characterize a suspect lymphoma in the mediastinum/thymus. Specific lymphomas arising or considered to derive from the thymus itself are as follows.
13.3.1 T-Lymphoblastic Lymphoma and Other T-Cell Lymphomas
The thymus is the main site of T-cell differentiation and education [17, 22]. During embryonic development, the T-cell lineage committed bone marrow progenitors enter the thymus via veins close to the corticomedullary junction and then migrate to the cortex. Thymopoiesis continues to occur in the thymus of human adults late in life despite the thymic involution [33].
Figure 13.1 shows the main characteristics of a T-Lymphoblastic Lymphoma. It should be noted that in the differential diagnosis of T-Lymphoblastic Lymphoma and a B1 thymoma, the evaluation of lymphoblast morphology is of little help, as they are similar in both tumors. Moreover, frequent mitosis and extensive necrosis are also seen in both tumors. Therefore, in an entirely necrotic tumor or in a small biopsy the diagnosis is often based on the evaluation of specific immunohistochemical markers targeting the neoplastic lymphoblasts, such as LMO2 [34, 35]. Previously, cyclin-dependent kinase-6 (CDK6) had been shown to stain only T-Lymphoblastic Lymphoma cells and subcapsular lymphoblasts in normal/hyperplastic thymuses [36]. Thymic remnant and epithelial cell (EC) networks, however, are very rarely found in T-Lymphoblastic Lymphomas, as the tumor growth is very destructive, in contrast to a B1 thymoma, where EC network may partially be seen even in necrotic tumors by appropriate immunohistochemical stains (cytokeratins).
As other rare T-cell lymphomas, mature, peripheral T-cell lymphomas have also been reported in the thymus/mediastinal lymph nodes [37]
13.3.2 Classic Hodgkin Lymphoma (cHL) and B Cell Lymphoma in the Thymus
Most lymphomas in the thymus derive from B cells. Thymic B cells, mainly located in the medulla or at the perivascular spaces, show a distinctive phenotype in comparison to other B cell subsets [38,39,40]; their relationship to peripheral B cell is still unclear [41]. These thymic B cells could give rise to B cell thymic lymphoma and to cHL of the thymus. In biopsies or surgical specimens of a lymphoid mass, it is difficult to find thymic remnants and other morphological findings that could indicate a thymic origin due to the fact that the neoplastic growth has a destructive action. However, when these remnants are seen they should be correctly recognized as such. Figure 13.2 shows a rare example of early phase of cHL in its intrathymic development.
13.3.2.1 Classic Hodgkin Lymphoma (cHL)
The most frequent subtype of cHL in the mediastinum is the nodular sclerosis (NS) variant [42], constituting about 50–70% of primary mediastinal lymphoma [43]. cHL-NS of the thymus is predominantly a tumor of the young age and primarily of females. In a sclerotic background with a polymorphic inflammatory population the demonstration of typical CD30+ cells, which are often very rare in the fibrous background (Fig. 13.3), is worthwhile to support the diagnosis. Reed-Sternberg cells (RS) are large with abundant eosinophilic cytoplasm, large double or multiple nuclei, and eosinophilic nucleoli; lacunar cells (LC) with small hyperlobated nuclei, small nucleoli, and clear, retracted cytoplasm are the cells more frequently associated to the NS subtype of cHL. As a specific pitfall, cHL induces reactive EC proliferation and/or cystic changes (Fig. 13.4) which may simulate a thymoma. Therefore, mediastinal cystic lesion should be extensively sampled because foci of cHL could be found in the wall [44,45,46]. The lymphoma usually forms large sclerotic masses with foci of necrosis and eosinophilic abscesses. cHL of the thymus is frequently mistaken with the primary mediastinal B cell lymphoma (PMBL), which also induces sclerotic reaction and may show RS-like cells. In fact, cHL-NS and PMBL have the same (B) cell origin [47, 48] and similar morphology and may show a similar clinical presentation.
13.3.2.2 Primary Mediastinal B Cell Lymphoma (PMBL)
This lymphoma usually forms bulky, solid masses of > 10 cm, with local symptoms of rapid growth, invasion, and compression of vital structures. Tumor development may represent a hematological emergency. At the time of primary diagnosis, the tumor is limited to the thorax with no involvement of lymph nodes or other lymphoid organs (only supraclavicular nodes are eventually reached). During relapse, the subdiaphragmatic lymphoma extension is frequent. This lymphoma was first described as mediastinal B cell lymphoma with sclerosis, as it is associated with a distinctive fibrosis [49]. Neoplastic cells are of variable size, frequently of large or medium-large size, sometimes with pale clear cytoplasm in the central part of the tumor and peripherally distributed lymphocytes in the sclerotic background (Fig. 13.5). Neoplastic infiltrating CD20+ B cells have pleomorphic nuclei, ranging from regular, round nuclei to irregular, multilobulated forms [50]. In certain cases, neoplastic cells are large with prominent eosinophilic nucleoli, which resemble RS cells or variants. CD30 is weakly or focally expressed, with lesser intensity than in cHL but MAL, a protein involved in lymphocyte signal transduction, present on a minor subpopulation of thymic medullary B cells, is expressed by PMBL [51]. CD23 is also a PMBL marker [52]. However, in the differential diagnosis of these mediastinal lymphomas (cHL, PMBL, and the gray zone lymphoma (GZL)) use of a panel of antibodies is recommended [32, 53, 54].
13.3.2.3 Gray Zone Lymphoma (GZL)
“Gray zone lymphoma” (GZL) or “B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma” [55] according to the 2017 WHO classification [23] originates in the mediastinum from a thymic medullary B cell [56]. GZL is a lymphoma of young patients (20 to 40 years) with a large anterior mediastinal mass, eventually involving the supraclavicular lymph nodes. Less frequently GZL occur in other localizations. GZL is a lymphoma with intermediate morphological and immunohistochemical characteristics (Fig. 13.6) between cHL and PMBL [48, 57]. In the case showed in Fig. 13.6, the large neoplastic cells coexpressed CD20, CD79a, CD30, PAX5, and the transcriptional factors OCT2 and BOB1. CD45 is negative. The genetical and epigenetic alterations reported show similarities and differences with those reported for PMBL and cHL. Consensus studies and updated diagnostic criteria were recently reported by Pilichowska et al. [58] and by Sarkozy et al., in the framework of the lymphoma study association (LYSA) [59] and in the recently published WHO classification of hematological malignancies [23]. A diagnostic scoring system was also proposed [60].
Table 13.2 shows comparison of main immunophenotypical characteristics of neoplastic lymphoid cells in cHL, PMBL, and GZL.
13.3.3 MALT Lymphoma of the Thymus
Among the peripheral B cell lymphomas occurring in the thymus, the most common is the mucosa-associated B cell lymphoma of MALT type or extranodal marginal zone lymphoma of MALT type [61]. This rare lymphoma type, often cystic, usually develops in association with autoimmune diseases [62] and is characterized by scant residual thymic EC network, lymphoepithelial (LE) lesions involving Hassall corpuscle (HC), and a monotonous infiltrate of marginal zone B cells [63] (Fig. 13.7).
13.3.4 Very Rare B Cell Lymphoma in the Mediastinum
In the setting of a systemic disease, B lymphoblastic lymphoma (B-Lb) may occur in the thymus. Rarely a primary mediastinal mass may also occur [64, 65], as shown in the Fig. 13.8, with B-Lb infiltrating the pericardium.
13.4 Neoplasms of Accessory Cells of the Lymphatic Tissue, with a Distinct Mention of Castleman Disease
Castleman disease (CD) is a morphological and clinically heterogeneous group of nonneoplastic lymphoproliferative disorder of the lymphoid tissue [24, 25, 27], occasionally giving rise to neoplasms of the constituting cells (both lymphoid and “accessory”) [26, 66]. In the mediastinum, the most frequent type of CD is the hyaline vascular (HV) type. The reader is referred to several recent reports/reviews on this complex disease [67, 68]. The follicular dendritic cell sarcomas (FDCS), a neoplasm of accessory cells of the lymphoid tissue, may occur in the framework of CD [69].
The heterogeneous group of very rare accessory cell neoplasms of the thymus includes those derived from Langerhans cells (Langerhans cell histiocytosis (Fig. 13.9) and Langerhans cell sarcoma) and Follicular dendritic cell sarcoma (FDCS); histiocytic sarcoma, interdigitating dendritic cell sarcoma, fibroblastic reticulum cell tumor, have been described in the mediastinum [23].
Accessory cell sarcomas have also been rarely reported to develop in GCT of the mediastinum [46, 70, 71]. Figure 13.10 represents the main features of a FDCS arising in CD.
13.5 Other Rare Hematological Neoplasias
In the framework of chronic myeloid leukemia (CML) a mediastinal mass and a blastic crisis may develop [72, 73]. Figure 13.11 shows the morphological features of cells infiltrating a sclerotic mediastinal stroma and results of the FISH for BCR/ABL. The cells were positive for CD45 and CD34. Subsequently, the FISH hybridization procedure confirmed that the blasts were BCR/ABL fusion positive. Moreover, hematological malignancies may arise also in the framework of GCT of the mediastinum [74,75,76].
13.6 Other Rare Tumors/Pseudotumors of the Mediastinum
13.6.1 Lymphadenoma
Lymphadenomas occur in salivary gland. Their thymic counterparts are rare and belong to benign salivary gland-type tumors of the thymus. These can be sebaceous or nonsebaceous. Microscopically, they show epithelial cells with or without sebaceous differentiation in the background of lymphoid stroma with germinal centers (Fig. 13.12). Epithelial cells show tubular or solid architecture, hence the term adenoma.
Thymoma should be considered in the differential diagnosis due to admixture of epithelial and lymphoid cells; however lack of characteristic tumor lobulation and irregular epithelial proliferation excludes thymoma.
13.6.2 Sclerosing Mediastinitis
Some of the fibrosing neoplasias/lymphomas previously described may simulate sclerosing (or fibrosing) mediastinitis (SM), a disease with immune/autoimmune pathogenesis, rarely affecting the mediastinum and the thymus [30, 77]. SM is part of the spectrum of IgG4-related disease (IgG4-RD) or it may be related to Histoplasmosis. This is an idiopathic fibroinflammatory disorder associated with hypergammaglobulinemia and increased serum levels of IgG, particularly IgG4. The newly formed fibrous tissue presents a marked IgG4+ plasma cell infiltrate [29, 78]. Figure 13.13 shows a case of IgG4-related disease developing in a salivary gland (Kuttner tumor) in an old woman. Cellular and storiform fibrosis; lymphoplasmacytic infiltration, with IgG4/IgG ratio of 40%; and >=50 IgG4 (+) cells/high power field (HPF) and obliterative phlebitis are among the diagnostic histological features of mediastinum and the other tissue localizations.
13.6.3 Mesenchymal Soft Tissue Tumors
Most of the mesenchymal tumors occurring in the anterior mediastinum show a thymic origin [79]. Mesenchymal soft tissue tumors of the mediastinum are similar in morphology and molecular features with their counterparts occurring in other sites. They account for 2% of all tumors in the mediastinum [79, 80]. A list of the histotypes more frequent in the anterior mediastinum is provided in a recent review [81]. Among soft tissue tumors, mediastinal sarcomas may either develop de novo or they may arise as “somatic-type” malignancy in a mediastinal GCT. The sarcomatous component develops more frequently in mediastinal GCT than in other sites [79]. Soft tissue tumors show a typical age and gender predilection or have specific associated diseases. Their diagnosis requires the use of immunohistochemistry by a specialized panel of antibodies, molecular testing, and the knowledge of the clinical setting [81].
13.6.3.1 Neoplasms with a Lipomatous Component and Fibroblastic Tumors
13.6.3.1.1 Liposarcoma
Lipomatous tumors account for up to 10% of mediastinal masses. Liposarcoma, in particular, is the most common primary malignant soft tissue tumor of the mediastinum.
A case of well-differentiated liposarcoma (Fig. 13.14) forms a huge tumor of 23 cm in diameter. The tumor shows a sclerosing pattern with focal loss of lipocytic differentiation; mature and immature (multivesicular) adipocytes embedded in fibro-myxoid (basophilic) stroma are seen. The lipoblasts contain several small fat droplets in the cytoplasm.
13.6.3.1.2 Thymolipoma
These are rare mediastinal tumors with benign clinical course which are also called as lipothymomas or simply lipomas due to scant or absent thymic tissue respectively. Thymic tissue may not be seen in small biopsies due to limited sampling. These are associated with MG and other autoimmune diseases.
Grossly, as the name suggests, they are soft and yellow, well-outlined fleshy lobulated tumors. The size can be very large and weigh up to 2 kg. No necrosis or hemorrhage is present (Fig. 13.15).
Microscopically, these show variable proportions of adipose tissue and thymic tissue. Thymic tissue shows admixture of epithelial and lymphocytic cells including HC. No atypia is seen in thymic or lipomatous components of the tumor (Figs. 13.16 and 13.17). Rare rhabdomyoblastic, fibrous, sebaceous, and smooth muscle differentiation is noted.
13.6.3.1.3 Angiomyolipoma
These are incidentally found rare mediastinal tumors, mostly reported in anterior mediastinum (Fig. 13.18). Mediastinal angiomyolipomas do not show close association with tuberous sclerosis.
Grossly these are large, soft, and yellow-colored tumors (Fig. 13.19). Histomorphologically they are same as other angiomyolipomas which are constituted by variable proportion of adipose tissue, smooth muscle, and ectatic blood vessels (Fig. 13.20). Residual thymic tissue can be seen in the vicinity of the tumor.
13.6.3.1.4 Lipofibroadenoma
It is a benign tumor of the thymus with only six case reports available in the literature [14, 82, 83]. It bears resemblance to fibroadenoma of the breast. They may arise de novo or in continuity with thymomas.
Grossly, the tumors are well-circumscribed and have a solid gray-white cut surface. Microscopically, the tumor has fibrotic and hyalinized stroma with entrapped epithelial cells and few interspersed TdT-negative lymphocytes (Fig. 13.21). Although differentiation from thymolipoma is based on predominance of adipose tissue in the thymolipoma and fibrous tissue in lipofibroadenoma, both may be considered in the spectrum of the same disease.
13.6.3.1.5 Solitary Fibrous Tumor and Malignant Solitary Fibrous Tumor
Among fibrous/spindle cell mesenchymal tumors, solitary fibrous tumor (SFT) [84, 85] is a prototype in mediastinum. SFT is, at present, considered a potentially malignant tumor even if morphology does not meet the criteria of the malignant SFT (Figs. 13.22 and 13.23). These tumors, considered to originate in the pleura, have a “patternless” architecture with randomly distributed hypocellular and hypercellular areas, sometimes embedded in keloid-like collagen. The criteria are same in mediastinum for predicting their malignant behavior, which include a high mitotic count (>4 mitoses per 2 mm2), high cellularity, pleomorphism, and necrosis [86]. The SFT cells are cytologically benign spindle shaped with few mitoses and positive for CD34 (Fig. 13.22). In addition to CD34, the positivity for STAT6 (Fig. 13.23) is specific, as almost all SFTs harbor NAB2-STAT6 fusion gene [87].
13.6.3.1.6 Desmoid Tumors
Desmoid tumors (Fig. 13.24) should be suspected in case of spindle cell, “benign-looking” tumor without mitotic activity and necrosis but with a diffuse infiltration of surrounding tissues (fat tissue or skeletal muscles). These tumors prevail in woman under hormonal influence and are completely resected with difficulty, as they usually infiltrate much beyond macroscopic borders [88]. Desmoid tumors are driven by alterations of the Wnt/APC/β-catenin pathway [89]; mutations in the gene-encoding β-catenin, CTNNB1, are highly prevalent in sporadic desmoid tumors. Therefore, the β-catenin is an important marker in the diagnosis of these tumors [90].
13.6.3.2 Vascular Tumors
13.6.3.2.1 Hemangioma
The hemangioma depicted in Fig. 13.25 occurred in a patient with massive facial hemangiomatosis. Among benign vascular tumors, several types of hemangioma variants (capillary, cavernous) have been described in the mediastinum or in the thymus. Tumor size ranges from a few centimeters to 20 cm. In the series by Moran and Suster, associated histological features included fatty metaplasia, fibrosis, smooth muscle overgrowth, and inflammation [91].
13.6.3.2.2 Epithelioid Hemangioendothelioma
Epithelioid hemangioendothelioma comes under vascular tumors with intermediate malignancy. Endothelial tumors of intermediate grade (hemangioendotheliomas) are characterized by local infiltrative growth and rare metastases (Fig. 13.26). These tumors show a spectrum of features with cells having abundant eosinophilic cytoplasm showing prominent vacuolization and intracellular lumen formation, few mitotic figures and myxoid changes in the stroma or more pronounced cytologic atypia, increased mitotic activity, and necrotic areas [92, 93].
13.6.3.2.3 Epithelioid Angiosarcoma
Epithelioid angiosarcoma (EAS) is a high-grade vascular neoplasm [94] characterized by high-grade cytology, necrosis, and abundance of mitosis (Fig. 13.27). Among vascular tumors, blood lakes, proliferation of slit-like vessels, and prominent nucleoli favor EAS. In the EAS series from Anderson et al. [95] CAMTA1 rearrangement was negative in all cases, whereas a WWTR1 complex abnormality was found in rare cases. In EAS, the positivity of at least one vascular marker is reported, which allows differentiation from primary thoracic epithelial malignancies. However, as a potential pitfall with epithelial tumors, 25% of EAS show keratin expression. With regard to a possible thymic origin, in two cases from a series of angiosarcoma of the anterior mediastinum, Weissferdt reported the presence of a thymic tissue rim at the tumor periphery [96].
13.6.3.3 Lymphangioma or Vascular Lymphatic Neoplasms/Malformations
13.6.3.3.1 Lymphangioma
Lymphangiomas are not considered true neoplasms but rather malformations of the lymphatic vasculature of uncertain origin [97, 98]. A thymic example is shown here (Fig. 13.28).
13.6.3.3.2 Kaposiform Lymphangiomatosis
Mediastinal kaposiform lymphangiomatosis (KLA) is histologically similar to its soft tissue counterparts and is characterized by poorly circumscribed nodules of tightly packed small capillary-sized vessels, Kaposi sarcoma-like areas with spindled cells, and absence of human herpesvirus 8 (HHV-8) immunoreactivity. A component of larger lymphatic vessels is often seen (Fig. 13.29). These tumors are positive for CD31, CD34, and D2-40. In KLA, the spindle cells are distributed in sparse and poorly marginated clusters. Reported mediastinal KLA cases were usually seen in pediatric population, with almost equal sex distribution, and associated consumptive coagulopathy (Kasabach-Merritt syndrome) as a major cause of tumor-related fatality [99, 100].
13.7 Adamantinoma-Like Ewing Family of Tumors
The initial microscopic diagnosis of this case was that of thymic carcinoma with squamous cell differentiation and unusual expression of CD99. However, the translocation t(11;22) (q24;q12)EWSR1-FLI1+ was found positive in tumor cells. This tumor shares the features of Ewing sarcoma (CD99 positivity, morphology of poorly differentiated component, and translocation) and squamous cell carcinoma (cytokeratin and squamous markers positive) (Fig. 13.30). This tumor is part of the Ewing family of tumors [80, 101, 102]. The t(11;22)(q24;q12) chromosomal translocation (EWS-FLI1 gene fusion) is highly specific for ES/PNET, as >90% of the tumors show this gene rearrangement [103].
13.8 Germ Cell Tumors of the Mediastinum
The true incidence of mediastinal GCT is difficult to establish due to the rarity of these tumors, the scarcity of large series published, and the variable criteria chosen to consider this tumor group. The anterior mediastinum and retroperitoneum constitute the main sites of extragenital GCT development. It has been suggested that the GCT arise from ectopic germ cells diffused during embryogenesis [104] or that they derive from germ cells diffused through the body during embryogenesis to contribute to important regulatory, hematological, or immunological processes [70]. The hypotheses on the origin of extragonadal GCT have been extensively discussed by Oosterhuis et al. [105]. Recently the same researchers proposed a comprehensive developmental pathogenetic model for the origin of all GCT [106].
For a detailed description, the reader is referred to a recent review on GCT [71], other previous papers [107, 108], and on the data published by the 2015 WHO classification of tumors of the lung, thymus, and pleura [14].
-
1.
Immature teratoma with embryonal carcinoma component of the mediastinum: two biopsies from the mass of a young man are shown. In the small first sample (surgical biopsy tissue) structures of different epithelial differentiation (glandular and squamoid) in a highly cellular undifferentiated stroma suggested immature teratoma (Fig. 13.31a). The second sample contained only small amount of tissue containing gland-like structures with numerous mitotic figures and karyorrhexis (Figs. 13.31b and 13.32). Immunophenotype of the cells of this sample corresponded to embryonal carcinoma. Mediastinal teratoma arising in the thymus has been reported and discussed elsewhere [109, 110].
-
2.
Seminoma: case of a young man with a mediastinal tumor. A monotonous infiltrate composed of large lymphocyte-like cells with associated granulomatous reaction is seen. The neoplastic cells were PLAP, CD117, and D2-40 positive (Fig. 13.33). Several series of seminomas occurring in the mediastinum have been reported and discussed [109,110,113].
-
3.
Yolk sac tumor: yolk sac tumor may present a variety of patterns including a pseudoadenocarcinoma pattern. Characteristic intracellular hyaline globules may be found in both yolk sac tumor and adenocarcinoma. A panel of immunohistochemical markers may allow the correct diagnosis. In this case the tumor cells were positive for AFP (alpha-fetoprotein), negative for mucin, and positive for SALL-4 [113]. Markers for embryonal carcinoma and choriocarcinoma (CD30 and beta-H‑CG) were negative (Fig. 13.34).
13.9 Metastases and Ectopic Tumors
13.9.1 Metastases
The incidence of thymic metastases from extrathymic tumors is difficult to establish, as at times perithymic lymph nodes are involved and thymus is secondarily involved by local extension of the disease. However, metastatic tumors in the mediastinum are very frequent [11]. Metastatic lung carcinomas involve the mediastinal lymph nodes more frequently than other tumors. Teratoma metastasized from the testis to the mediastinal lymph nodes is shown in Fig. 13.35. Melanoma metastasis has been also reported in the thymus (Fig. 13.36). Immunohistochemistry plays an important role in the identification or confirmation of the primary site [114]. The possibility of very unusual primary thymic neoplasms should also be considered, as primary thymic melanomas have been reported [115].
13.9.2 Ectopic Tumors
Among ectopic tumors, intrathymic ectopic parathyroid adenomas (Fig. 13.37) are reported. The occurrence of ectopic parathyroid tissue in the anterior mediastinum is rather frequent and cases of parathyroid adenoma have been reported [116]. These ectopic tumors can be responsible for primary hyperparathyroidism. A case of primary juvenile sporadic hyperparathyroidism due to a parathyroid adenoma developing in a supernumerary fifth intrathymic parathyroid has been reported [117].
13.10 Conclusions
Considering the examples shown here, which represent only a limited part of the infinite histotypes so far described, the diagnosis of tumors of the mediastinum requires experience and a multidisciplinary approach of pathologists and clinicians. Use of multiple immunohistochemical markers is essential to establish the correct diagnosis. Thoracic pathologists, pediatric pathologists, hematopathologists, soft tissue tumors pathologists, thoracic surgeons, and endocrinologists should contribute to this challenging field of diagnostics. Search for genomic changes/chromosomal translocations should also become part of the routine investigations in some cases. The referral to center of expertise in mediastinal/thoracic rare tumors and the recent development of networks in thoracic oncology (such as in Europe the network established in EURACAN) (http://euracan.ern-net.eu) is expected to provide better integration of diagnosis, clinical care, and research.
References
Azarow KS, Pearl RH, Zurcher R, Edwards FH, Cohen AJ. Primary mediastinal masses. A comparison of adult and pediatric populations. J Thorac Cardiovasc Surg. 1993;106(1):67–72.
Liu T, Al-Kzayer LFY, Xie X, Fan H, Sarsam SN, Nakazawa Y, et al. Mediastinal lesions across the age spectrum: a clinicopathological comparison between pediatric and adult patients. Oncotarget. 2017;8(35):59845–53. https://doi.org/10.18632/oncotarget.17201.
Naeem F, Metzger ML, Arnold SR, Adderson EE. Distinguishing benign mediastinal masses from malignancy in a histoplasmosis-endemic region. J Pediatr. 2015;167(2):409–15. https://doi.org/10.1016/j.jpeds.2015.04.066.
Szolkowska M, Szczepulska-Wojcik E, Maksymiuk B, Burakowska B, Winiarski S, Gatarek J, et al. Primary mediastinal neoplasms: a report of 1,005 cases from a single institution. J Thorac Dis. 2019;11(6):2498–511. https://doi.org/10.21037/jtd.2019.05.42.
Takeda S, Miyoshi S, Akashi A, Ohta M, Minami M, Okumura M, et al. Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution. J Surg Oncol. 2003a;83(1):24–30. https://doi.org/10.1002/jso.10231.
Carter BW, Benveniste MF, Marom EM. Diagnostic approach to the anterior/prevascular mediastinum for radiologists. Mediastinum. 2018;3:18. https://doi.org/10.21037/med.2018.12.03.
Carter BW, Marom EM, Detterbeck FC. Approaching the patient with an anterior mediastinal mass: a guide for clinicians. J Thorac Oncol. 2014;9(9 Suppl 2):S102–9. https://doi.org/10.1097/JTO.0000000000000294.
Rashidfarokhi M, Gupta J, Leytin A, Epelbaum O. Ectopic anterior mediastinal pathology in the chest: radiologic-pathologic correlation of unexpected encounters with the “Terrible Ts”. J Clin Imaging Sci. 2016;6:49. https://doi.org/10.4103/2156-7514.197025.
Weissferdt A, Moran CA. The spectrum of ectopic thymomas. Virchows Arch. 2016;469(3):245–54. https://doi.org/10.1007/s00428-016-1967-0.
Middleton G. Involvement of the thymus by metastic neoplasms. Br J Cancer. 1966;20(1):41–6.
Suster S, Moran C. Diagnostic pathology: thoracic. Philadelphia, PA: Elsevier; 2012.
Petersdorf SH, Wood DE. Lymphoproliferative disorders presenting as mediastinal neoplasms. Semin Thorac Cardiovasc Surg. 2000;12(4):290–300.
Addis BJ, Isaacson PG. Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin. Histopathology. 1986;10(4):379–90.
Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of tumours of the lung, pleura, thymus and heart. Lyon: International Agency for Research on Cancer – IARC Press; 2015.
Chen L, Wang M, Fan H, Hu F, Liu T. Comparison of pediatric and adult lymphomas involving the mediastinum characterized by distinctive clinicopathological and radiological features. Sci Rep. 2017;7(1):2577. https://doi.org/10.1038/s41598-017-02720-1.
Maeshima AM, Taniguchi H, Suzuki T, Yuda S, Toyoda K, Yamauchi N, et al. Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997–2016. Int J Hematol. 2017;106(5):675–80. https://doi.org/10.1007/s12185-017-2331-0.
Bassan R, Maino E, Cortelazzo S. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. Eur J Haematol. 2016;96(5):447–60. https://doi.org/10.1111/ejh.12722.
Duwe BV, Sterman DH, Musani AI. Tumors of the mediastinum. Chest. 2005;128(4):2893–909. https://doi.org/10.1378/chest.128.4.2893.
Johnson PW. IV. Masses in the mediastinum: primary mediastinal lymphoma and intermediate types. Hematol Oncol. 2015;33(Suppl 1):29–32. https://doi.org/10.1002/hon.2212.
Marchevsky A, Marx A, Ströbel P, Suster S, Venuta F, Marino M, et al. Policies and reporting guidelines for small biopsy specimens of mediastinal masses. J Thorac Oncol. 2011;6(7 Suppl 3):S1724–9. https://doi.org/10.1097/JTO.0b013e31821ea57c.
Orazi A, Foucar K, Knowles DM, Weiss LE. Knowles neoplastic hematopathology. Philadelphia, PA: Wolters Kluwer Health; 2014.
Pan Y, Li GD, Liu WP, Zhang WY, Tang Y, Li FY. Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients. Zhonghua Bing Li Xue Za Zhi. 2009;38(12):810–5.
Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, et al. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer – IARC Press; 2017.
Castleman B. Tumors of the thymus gland. Washington, DC: Armed Forces Institute of Pathology; 1955.
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9(4):822–30.
Desai SB, Pradhan SA, Chinoy RF. Mediastinal Castleman's disease complicated by follicular dendritic cell tumour. Indian J Cancer. 2000;37(4):129–32.
Kligerman SJ, Auerbach A, Franks TJ, Galvin JR. Castleman disease of the thorax: clinical, radiologic, and pathologic correlation: from the radiologic pathology archives. Radiographics. 2016;36(5):1309–32. https://doi.org/10.1148/rg.2016160076.
O’Reilly PE, Joshi VV, Holbrook CT, Weisenburger DD. Multicentric Castleman’s disease in a child with prominent thymic involvement: a case report and brief review of the literature. Mod Pathol. 1993;6(6):776–80.
Detlefsen S. IgG4-related disease: a systemic condition with characteristic microscopic features. Histol Histopathol. 2013;28(5):565–84. https://doi.org/10.14670/hh-28.565.
Simonetti S, Perez Munoz N, Lopez Vivancos J, Sanchez Sitjes L, Herranz Perez JC, Leal Bohorquez N, et al. IgG4-related disease in thymus. A very rare case of chronic fibrosis mimicking sarcoidosis. Tumori. 2017;103(Suppl. 1):e19–24. https://doi.org/10.5301/tj.5000687.
Laurent C, Do C, Gourraud PA, de Paiva GR, Valmary S, Brousset P. Prevalence of common non-hodgkin lymphomas and subtypes of hodgkin lymphoma by nodal site of involvement: a systematic retrospective review of 938 cases. Medicine. 2015;94(25):e987. https://doi.org/10.1097/MD.0000000000000987.
Marino M, Ascani S. An overview on the differential diagnostics of tumors of the anterior-superior mediastinum: the pathologist’s perspective. Mediastinum. 2019;3(6) https://doi.org/10.21037/med.2018.12.01.
Hale LP. Histologic and molecular assessment of human thymus. Ann Diagn Pathol. 2004;8(1):50–60.
Jevremovic D, Roden AC, Ketterling RP, Kurtin PJ, McPhail ED. LMO2 is a specific marker of T-lymphoblastic leukemia/lymphoma. Am J Clin Pathol. 2016;145(2):180–90. https://doi.org/10.1093/ajcp/aqv024.
Menter T, Gasser A, Juskevicius D, Dirnhofer S, Tzankov A. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms. Appl Immunohistochem Mol Morphol. 2015;23(7):491–8. https://doi.org/10.1097/PAI.0000000000000107.
Chilosi M, Doglioni C, Yan Z, Lestani M, Menestrina F, Sorio C, et al. Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am J Pathol. 1998;152(1):209–17.
Kakuta N, Sumitani M, Sugitani A, Nakahama K, Miki Y, Syoji S. Mediastinal peripheral T-cell lymphoma diagnosed by repeated biopsies after an initial diagnosis of fibrosing mediastinitis. Respirol Case Rep. 2017;5(6):e00272. https://doi.org/10.1002/rcr2.272.
Fend F, Nachbaur D, Oberwasserlechner F, Kreczy A, Huber H, Müller-Hermelink HK. Phenotype and topography of human thymic B cells. An immunohistologic study. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;60(6):381–8.
Isaacson PG, Norton AJ, Addis BJ. The human thymus contains a novel population of B lymphocytes. Lancet. 1987;2(8574):1488–91.
Perera J, Huang H. The development and function of thymic B cells. Cell Mol Life Sci. 2015;72(14):2657–63. https://doi.org/10.1007/s00018-015-1895-1.
Yamano T, Nedjic J, Hinterberger M, Steinert M, Koser S, Pinto S, et al. Thymic B cells are licensed to present self antigens for central T Cell tolerance induction. Immunity. 2015;42(6):1048–61. https://doi.org/10.1016/j.immuni.2015.05.013.
Piña-Oviedo S, Moran CA. Primary mediastinal classical hodgkin lymphoma. Adv Anat Pathol. 2016;23(5):285–309. https://doi.org/10.1097/PAP.0000000000000119.
Rauthe S, Rosenwald A. Mediastinal lymphomas. Pathologe. 2016;37(5):457–64. https://doi.org/10.1007/s00292-016-0199-z.
Marino M, Roden A. The evolution of the histopathologic classification of thymic epithelial tumors (Review). Mediastinum. 2018;2(9) https://doi.org/10.21037/med.2018.01.04.
Suster S, Moran CA. Malignant thymic neoplasms that may mimic benign conditions. Semin Diagn Pathol. 1995;12(1):98–104.
den Bakker MA, Oosterhuis JW. Tumours and tumour-like conditions of the thymus other than thymoma; a practical approach. Histopathology. 2009;54(1):69–89. https://doi.org/10.1111/j.1365-2559.2008.03177.x.
Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198(6):851–62. https://doi.org/10.1084/jem.20031074.
Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102(12):3871–9. https://doi.org/10.1182/blood-2003-06-1841.
Menestrina F, Chilosi M, Bonetti F, Lestani M, Scarpa A, Novelli P, et al. Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases. Histopathology. 1986;10(6):589–600.
Paulli M, Strater J, Gianelli U, Rousset MT, Gambacorta M, Orlandi E, et al. Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases. Hum Pathol. 1999;30(2):178–87. https://doi.org/10.1016/s0046-8177(99)90273-3.
Copie-Bergman C, Plonquet A, Alonso MA, Boulland ML, Marquet J, Divine M, et al. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod Pathol. 2002;15(11):1172–80. https://doi.org/10.1097/01.MP.0000032534.81894.B3.
Aladily TN, Mansour A, Alsughayer A, Sughayer M, Medeiros LJ. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma. Ann Diagn Pathol. 2019;40:72–6. https://doi.org/10.1016/j.anndiagpath.2019.04.009.
Hoeller S, Zihler D, Zlobec I, Obermann EC, Pileri SA, Dirnhofer S, et al. BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma. Histopathology. 2010;56(2):217–28. https://doi.org/10.1111/j.1365-2559.2009.03462.x.
O’Malley DP, Fedoriw Y, Weiss LM. Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A proposed scoring system. Appl Immunohistochem Mol Morphol. 2016;24(8):535–40. https://doi.org/10.1097/PAI.0000000000000236.
Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, Killian JK, Sun HW, et al. Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin’s lymphoma and primary mediastinal large B-cell lymphoma. Haematologica. 2011;96(4):558–66. https://doi.org/10.3324/haematol.2010.033167.
Traverse-Glehen A, Pittaluga S, Gaulard P, Sorbara L, Alonso MA, Raffeld M, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 2005;29(11):1411–21.
Hutchinson CB, Wang E. Primary mediastinal (thymic) large B-cell lymphoma: a short review with brief discussion of mediastinal gray zone lymphoma. Arch Pathol Lab Med. 2011;135(3):394–8. https://doi.org/10.1043/2009-0463-RSR.1.
Pilichowska M, Pittaluga S, Ferry JA, Hemminger J, Chang H, Kanakry JA, et al. Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Adv. 2017;1(26):2600–9. https://doi.org/10.1182/bloodadvances.2017009472.
Sarkozy C, Copie-Bergman C, Damotte D, Ben-Neriah S, Burroni B, Cornillon J, et al. Gray-zone lymphoma between cHL and large B-cell lymphoma: a histopathologic series from the LYSA. Am J Surg Pathol. 2019;43(3):341–51. https://doi.org/10.1097/pas.0000000000001198.
Sarkozy C, Molina T, Ghesquières H, Michallet AS, Dupuis J, Damotte D, et al. Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association. Haematologica. 2017;102(1):150–9. https://doi.org/10.3324/haematol.2016.152256.
McCluggage WG, McManus K, Qureshi R, McAleer S, Wotherspoon AC. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) of thymus. Hum Pathol. 2000;31(2):255–9.
Kim JM. Primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue-type in the thymus of a patient with Sjögren's syndrome and rheumatoid arthritis. J Korean Med Sci. 2003;18(6):897–900. https://doi.org/10.3346/jkms.2003.18.6.897.
Kang LY, Ho SP, Chou YP. Primary thymic mucosa-associated lymphoid tissue lymphoma with multiple thin walled lung cysts: case report and literature review. Chin J Cancer Res. 2013;25(3):354–7. https://doi.org/10.3978/j.issn.1000-9604.2013.06.07.
Maitra A, McKenna RW, Weinberg AG, Schneider NR, Kroft SH. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol. 2001;115(6):868–75. https://doi.org/10.1309/Q5GV-3K00-WAC6-BBUB.
Sander CA, Jaffe ES, Gebhardt FC, Yano T, Medeiros LJ. Mediastinal lymphoblastic lymphoma with an immature B-cell immunophenotype. Am J Surg Pathol. 1992;16(3):300–5.
Lin O, Frizzera G. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases. Am J Surg Pathol. 1997;21(11):1295–306.
Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017;129(12):1646–57. https://doi.org/10.1182/blood-2016-10-746933.
Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer Control. 2014;21(4):266–78.
Wu YL, Wu F, Xu CP, Chen GL, Zhang Y, Chen W, et al. Mediastinal follicular dendritic cell sarcoma: a rare, potentially under-recognized, and often misdiagnosed disease. Diagn Pathol. 2019;14(1):5. https://doi.org/10.1186/s13000-019-0779-3.
Busch J, Seidel C, Zengerling F. Male extragonadal germ cell tumors of the adult. Oncol Res Treat. 2016;39(3):140–4. https://doi.org/10.1159/000444271.
Kalhor N, Moran CA. Primary germ cell tumors of the mediastinum: a review. Mediastinum. 2018;2:4. https://doi.org/10.21037/med.2017.12.01.
Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21(2):340–50. https://doi.org/10.1038/sj.leu.2404491.
Wong WS, Loong F, Ooi GC, Tse TC, Chim CS. Primary granulocytic sarcoma of the mediastinum. Leuk Lymphoma. 2004;45(9):1931–3. https://doi.org/10.1080/10428190310001645898.
Bremmer F, Ströbel P. Mediastinal germ cell tumors. Der Pathologe. 2016;37(5):441–8. https://doi.org/10.1007/s00292-016-0196-2.
Ikdahl T, Josefsen D, Jakobsen E, Delabie J, Fossa SD. Concurrent mediastinal germ-cell tumour and haematological malignancy: case report and short review of literature. Acta Oncol. 2008;47(3):466–9. https://doi.org/10.1080/02841860701636272.
Zhao GQ, Dowell JE. Hematologic malignancies associated with germ cell tumors. Expert Rev Hematol. 2012;5(4):427–37. https://doi.org/10.1586/ehm.12.24.
Masunaga A, Ishibashi F, Koh E, Oide T, Sekine Y, Hiroshima K. Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report. Diagn Pathol. 2018;13(1):6. https://doi.org/10.1186/s13000-018-0684-1.
Ishimoto H, Yatera K, Shimabukuro I, Matsuki Y, Hanaka T, Oda K, et al. Case of immunoglobulin G4 (IgG4)-related disease diagnosed by transbronchial lung biopsy and endobronchial ultrasound-guided transbronchial needle aspiration. J UOEH. 2014;36(4):237–42.
den Bakker MA, Marx A, Mukai K, Strobel P. Mesenchymal tumours of the mediastinum-part I. Virchows Arch. 2015a;467(5):487–500. https://doi.org/10.1007/s00428-015-1830-8.
den Bakker MA, Marx A, Mukai K, Strobel P. Mesenchymal tumours of the mediastinum--part II. Virchows Arch. 2015b;467(5):501–17. https://doi.org/10.1007/s00428-015-1832-6.
den Bakker M, Marx A, Ströbel P. The pathology of mesenchymal tumors of the mediastinum. Mediastinum. 2018;2:42. https://doi.org/10.21037/med.2018.05.01.
Makdisi G, Roden AC, Shen KR. Successful resection of giant mediastinal lipofibroadenoma of the thymus by video-assisted thoracoscopic surgery. Ann Thorac Surg. 2015;100(2):698–700.
Hui M, Paul TR, Uppin SG, Jyothi N. Lipofibroadenoma with B1 thymoma: A case report of a rare thymic tumor. Indian J Pathol Microbiol. 2018;61(4):630–32.
Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol. 2014;27(3):390–5. https://doi.org/10.1038/modpathol.2013.164.
Tsubochi H, Endo T, Sogabe M, Endo S, Morinaga S, Dobashi Y. Solitary fibrous tumor of the thymus with variegated epithelial components. Int J Clin Exp Pathol. 2014;7(11):7477–84.
Fletcher C, Bridge J, Hogendoorn P, Mertens F. World Health Organization classification of tumours of soft tissue and bone. Lyon: International Agengy for Research on Cancer – IARC Press; 2013.
Yoshida A, Tsuta K, Ohno M, Yoshida M, Narita Y, Kawai A, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol. 2014;38(4):552–9. https://doi.org/10.1097/pas.0000000000000137.
Lee JH, Jeong JS, Kim SR, Jin GY, Chung MJ, Kuh JH, et al. Mediastinal desmoid tumor with remarkably rapid growth: a case report. Medicine. 2015;94(52):e2370. https://doi.org/10.1097/md.0000000000002370.
Penel N, Chibon F, Salas S. Adult desmoid tumors: biology, management and ongoing trials. Curr Opin Oncol. 2017;29(4):268–74. https://doi.org/10.1097/cco.0000000000000374.
Mullen JT, DeLaney TF, Rosenberg AE, Le L, Iafrate AJ, Kobayashi W, et al. Beta-catenin mutation status and outcomes in sporadic desmoid tumors. Oncologist. 2013;18(9):1043–9. https://doi.org/10.1634/theoncologist.2012-0449.
Moran CA, Suster S. Mediastinal hemangiomas: a study of 18 cases with emphasis on the spectrum of morphological features. Hum Pathol. 1995;26(4):416–21. https://doi.org/10.1016/0046-8177(95)90143-4.
Mansour Z, Neuville A, Massard G. Mediastinal epithelioid haemangioendothelioma: a rare mediastinal tumour. Interact Cardiovasc Thorac Surg. 2010;10(1):122–4. https://doi.org/10.1510/icvts.2009.216978.
Suster S, Moran CA, Koss MN. Epithelioid hemangioendothelioma of the anterior mediastinum. Clinicopathologic, immunohistochemical, and ultrastructural analysis of 12 cases. Am J Surg Pathol. 1994;18(9):871–81.
Hart J, Mandavilli S. Epithelioid angiosarcoma: a brief diagnostic review and differential diagnosis. Arch Pathol Lab Med. 2011;135(2):268–72. https://doi.org/10.1043/1543-2165-135.2.268.
Anderson T, Zhang L, Hameed M, Rusch V, Travis WD, Antonescu CR. Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions. Am J Surg Pathol. 2015;39(1):132–9. https://doi.org/10.1097/PAS.0000000000000346.
Weissferdt A, Kalhor N, Suster S, Moran CA. Primary angiosarcomas of the anterior mediastinum: a clinicopathologic and immunohistochemical study of 9 cases. Hum Pathol. 2010;41(12):1711–7. https://doi.org/10.1016/j.humpath.2010.05.003.
Licci S, Puma F, Sbaraglia M, Ascani S. Primary intrathymic lymphangioma. Am J Clin Pathol. 2014;142(5):683–8. https://doi.org/10.1309/AJCPGDRPIMYSSX7U.
Zhou H, Zhong C, Fu Q, Tang S, Luo Q, Yu L, et al. Thoracoscopic resection of a huge mediastinal cystic lymphangioma. J Thorac Dis. 2017;9(10):E887–9. https://doi.org/10.21037/jtd.2017.09.97.
Ji Y, Chen S, Peng S, Xia C, Li L. Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences. Orphanet J Rare Dis. 2019;14(1):165. https://doi.org/10.1186/s13023-019-1147-9.
Ozeki M, Nozawa A, Kawamoto N, Fujino A, Hirakawa S, Fukao T. Potential biomarkers of kaposiform lymphangiomatosis. Pediatr Blood Cancer. 2019;66(9):e27878. https://doi.org/10.1002/pbc.27878.
Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR. Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol. 2015;39(9):1267–74. https://doi.org/10.1097/pas.0000000000000460.
Reali A, Mortellaro G, Allis S, Trevisiol E, Anglesio SM, Bartoncini S, et al. A case of primary mediastinal Ewing's sarcoma/primitive neuroectodermal tumor presenting with initial compression of superior vena cava. Ann Thorac Med. 2013;8(3):121–3. https://doi.org/10.4103/1817-1737.109834.
Bae SH, Hwang JH, Da Nam B, Kim HJ, Kim KU, Kim DW, et al. Multiple Ewing Sarcoma/Primitive Neuroectodermal Tumors in the Mediastinum: A Case Report and Literature Review. Medicine (Baltimore). 2016;95(7):e2725. https://doi.org/10.1097/md.0000000000002725.
Takeda S, Miyoshi S, Ohta M, Minami M, Masaoka A, Matsuda H. Primary germ cell tumors in the mediastinum: a 50-year experience at a single Japanese institution. Cancer. 2003b;97(2):367–76. https://doi.org/10.1002/cncr.11068.
Oosterhuis JW, Stoop H, Honecker F, Looijenga LH. Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. Int J Androl. 2007;30(4):256–63.; discussion 263-4. https://doi.org/10.1111/j.1365-2605.2007.00793.x.
Oosterhuis JW, Looijenga LHJ. Human germ cell tumours from a developmental perspective. Nat Rev Cancer. 2019;19:522–37. https://doi.org/10.1038/s41568-019-0178-9.
Malagón HD, Montiel DP. Mediastinal germ cell tumours. Diagn Histopathol. 2010;16(5):228–36. https://doi.org/10.1016/j.mpdhp.2010.03.002.
Moran CA, Suster S. Primary germ cell tumors of the mediastinum: I. Analysis of 322 cases with special emphasis on teratomatous lesions and a proposal for histopathologic classification and clinical staging. Cancer. 1997;80(4):681–90.
Alkan M, Karnak I, Ciftci AO, Tanyel FC. Thymic teratoma or thymic remnant attached to mediastinal teratoma? The cellular origin of mediastinal teratomas revisited. Eur J Pediatr Surg. 2004;14(2):117–9. https://doi.org/10.1055/s-2004-817842.
Paradies G, Zullino F, Orofino A, Leggio S. Mediastinal teratomas in children. Case reports and review of the literature. Ann Ital Chir. 2013;84(4):395–403.
Moran CA, Suster S, Przygodzki RM, Koss MN. Primary germ cell tumors of the mediastinum: II. Mediastinal seminomas--a clinicopathologic and immunohistochemical study of 120 cases. Cancer. 1997;80(4):691–8. https://doi.org/10.1002/(sici)1097-0142(19970815)80:4<691::aid-cncr7>3.0.co;2-q.
Sung MT, Maclennan GT, Lopez-Beltran A, Zhang S, Montironi R, Cheng L. Primary mediastinal seminoma: a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases. Am J Surg Pathol. 2008;32(1):146–55. https://doi.org/10.1097/PAS.0b013e3181379edf.
Weissferdt A, Rodriguez-Canales J, Liu H, Fujimoto J, Wistuba II, Moran CA. Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers. Hum Pathol. 2015;46(3):376–83. https://doi.org/10.1016/j.humpath.2014.11.009.
Zhang K, Deng H, Cagle PT. Utility of immunohistochemistry in the diagnosis of pleuropulmonary and mediastinal cancers: a review and update. Arch Pathol Lab Med. 2014;138(12):1611–28. https://doi.org/10.5858/arpa.2014-0092-RA.
Alli PM, Crain BJ, Heitmiller R, Argani P. Malignant melanoma presenting as an intrathymic tumor: a primary thymic melanoma? Arch Pathol Lab Med. 2000;124(1):130–4. https://doi.org/10.1043/0003-9985(2000)124<0130:mmpaai>2.0.co;2.
Naik D, Jebasingh KF, Cherian AJ, Dasgupta R. Ectopic thymic parathyroid adenoma. BMJ Case Rep. 2014;2014 https://doi.org/10.1136/bcr-2014-206634.
Spinelli C, Liserre J, Pucci V, Massart F, Grosso M, Brandi ML. Primary hyperparathyroidism: fifth parathyroid intrathymic adenoma in a young patient. J Pediatr Endocrinol Metab. 2012;25(7–8):781–4. https://doi.org/10.1515/jpem-2012-0101.
Acknowledgments
The authors thank Dr Enzo Gallo for the photographical assistance and Mrs Arianna Papadantonakis for her technical assistance.
Conflicts of Interest
The authors have no conflicts of interest to declare.
Funding
Funding The authors received no funding for this project.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Marino, M., Szolkowska, M., Ascani, S. (2020). Lymphomas and Other Rare Tumors of the Thymus. In: Jain, D., Bishop, J.A., Wick, M.R. (eds) Atlas of Thymic Pathology. Springer, Singapore. https://doi.org/10.1007/978-981-15-3164-4_13
Download citation
DOI: https://doi.org/10.1007/978-981-15-3164-4_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-3163-7
Online ISBN: 978-981-15-3164-4
eBook Packages: MedicineMedicine (R0)